BV

Birendra Vikram Singh

Director DIN 07241222
DIN 07241222 First appointment Aug 2015
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Aug 2015
Shareholding value β€’β€’β€’β€’ Premium profile

About Birendra Vikram Singh

Data last updated:

Birendra Vikram Singh was a Director at Mr Medicine India Private Limited (from 2015) and Director at Lkp Devlopers Private Limited (from 2017).

DIN 07241222
First Appointment 11 Aug 2015
Oldest Company Age 11 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mr Medicine India Private Limited U33110DL2015PTC283916
Director11 Aug 20152015Strike Off
Lkp Devlopers Private Limited U45309DL2017PTC324639
Director09 Oct 20172017₹68.6 Lakh (FY 2018)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Mr Medicine India Private Limited
Lkp Devlopers Private Limited
Premium access

Shareholding and investment profile for Birendra Vikram Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Birendra Vikram Singh

Birendra Vikram Singh was first appointed on 11 Aug 2015 as Director at Mr Medicine India Private Limited. The most recent appointment on record is 09 Oct 2017 at Lkp Devlopers Private Limited.

Birendra Vikram Singh held 2 earlier board appointments: Mr Medicine India Private Limited (Director, from 11 Aug 2015); Lkp Devlopers Private Limited (Director, from 09 Oct 2017).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available